ManagedCareCGM

Continuous Glucose Monitoring

Education for Managed Care, Pharmacy, and Payer Professionals

Intermittently Scanned CGM: Novel Glucose-sensing Technology and Hypoglycaemia in Type 1 Diabetes: A Multicentre, Non-masked, Randomised Controlled Trial

Return to Resources *Product Comparison AMCP Formulary Dossiers Clinical Studies Coverage and Benefit Design Featured Resources Health Economics and Outcomes Research (HEOR) Non-CE Education Resources Other Resources Professional Guidelines Real-World Evidence Review Articles
Tags:

Source: The Lancet

Key Takeaway: This study conducted in Europe with over 300 participants found novel flash glucose testing reduced the time adults with well controlled type 1 diabetes spent in hypoglycaemia. Future studies are needed to assess the effectiveness of this technology in patients with less well controlled diabetes and in younger age groups.

Click here to access.

Jointly Provided by

Jointly Provided by

This activity is supported by an independent educational grant from DexCom, Inc.